Enhancing automated chyme reinfusion therapy with The Insides System
- Conditions
- OstomySmall bowel stomaenteroatmospheric fistulaDiet and Nutrition - Other diet and nutrition disordersSurgery - Other surgeryOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
- Registration Number
- ACTRN12624000427572
- Lead Sponsor
- The Insides Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
•Adults >=18 years of age, with defunctioning loop/double barrel/abcarian small bowel stoma or enterocutaneous fistula
•If colonic anastomosis present, anastomotic leak and distal obstruction will be excluded e.g. via gastrografin enema or CT scan with rectal contrast or clinical evaluation such as endoscopy
•If ECF patient, gastrografin enema or CT scan with rectal contrast or clinical evaluation such as endoscopy to ensure patent distal intestine
•Distal limb of stoma can be intubated with a minimum of 22 Fr feeding tube (dilatation of stoma orifice strictures is allowable)
•Able to independently manage their stoma
•Proximal and distal outlets contained within one ostomy appliance
•Able to understand the risks/benefits of the study
•Able to give informed consent
•<18 years of age
•Anastomotic leak or perforation
•Insufficient distal access or distal obstruction
•Current pregnancy
•Separated proximal and distal stomas that are pouched with separate ostomy appliances
•Unable understand the risks/benefits of the study and to give informed consent
•Unable to independently manage a stoma
•Inability to intubate the distal stoma
•Previous or current Clostridium difficile colitis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety of a new version of The Insides System [Face to face contact to collect verbal and written (study questionnaire) patient and nurse feedback of their experience when using the device. The study questionnaire has been developed specifically for this study. Daily for 2 weeks from the start of the intervention. ];Efficacy of a new version of The Insides System[Face to face contact to collect verbal and written (study questionnaire) patient and nurse feedback of their experience when using the device. The study questionnaire has been developed specifically for this study. Daily for 2 weeks from the start of the intervention. ]
- Secondary Outcome Measures
Name Time Method Patient usability of the device[Face to face contact to collect verbal and written (study questionnaire) patient and nurse feedback of their experience when using the device. The study questionnaire has been developed specifically for this study. Daily for 2 weeks from the start of the intervention. ];Identify barriers to use of the device[Face to face contact to collect verbal and written (study questionnaire) patient and nurse feedback of their experience when using the device. The study questionnaire has been developed specifically for this study. Daily for 2 weeks from the start of the intervention. ]